scispace - formally typeset
Open AccessJournal ArticleDOI

Electronic data capture - Narrowing the gap between clinical and data management.

Deven Babre
- 01 Jan 2011 - 
- Vol. 2, Iss: 1, pp 1-3
Reads0
Chats0
About
This article is published in Perspectives in Clinical Research.The article was published on 2011-01-01 and is currently open access. It has received 15 citations till now. The article focuses on the topics: Electronic data capture & Data management.

read more

Citations
More filters

Department of Computer Science and Engineering

TL;DR: In this article, the authors present a survey of postgraduate students: Vladimír Arnošt, Daniel Čapek, Rudolf Čejka, Dao Minh, TomᚠDulík, Martin Hrubý, Radek Kočí, Petr Kotásek, Marek Křejpský and Bohuslav KŘena, Vladislav Kubíček.
Journal ArticleDOI

Using e-technologies in clinical trials.

TL;DR: Using e-technologies to design and implement clinical trials has the potential to reach a wide audience, making trials more efficient while also reducing costs; however, researchers should be cautious when adopting these tools given the many challenges in using new technologies, as well as threats to participant privacy/confidentiality.

Pressures at the front lines : investigative sites and contract research organizations in Canadian clinical trials

TL;DR: In this article, the authors present a Table of Table of contents of the paper "A.K.A., Table of Contents" and Table of Content: https://www.goup.com/
Journal ArticleDOI

Medical Registry Data Collection Efficiency: A Crossover Study Comparing Web-Based Electronic Data Capture and a Standard Spreadsheet.

TL;DR: Data collection for a registry of patients who underwent coronary computed tomography angiography in the emergency setting with an EDC tool was faster than using a spreadsheet, which in turn allowed more efficient follow-up of cases.
Journal ArticleDOI

Paperless clinical trials: Myth or reality?

TL;DR: The adaptation of paperless processes may require major changes to existing procedures, but this is in the best interests of pharmaceutical organizations to remain competitive because a paperless clinical trial would lead to a consistent and streamlined framework.